Asst. Prof. Meltem Topalgokceli Selam

Asst. Prof. Meltem Topalgokceli Selam
Academic Title :
Asst. Prof.

Asst. Prof. Dr. Meltem Topalgökçeli Selam is a medical oncologist at Liv Hospital Ulus in Istanbul, Turkey. Her clinical interests include the diagnosis and medical management of solid tumors, particularly gastrointestinal and colorectal cancers, ovarian and other gynecological cancers, lung cancer, breast cancer, and urological malignancies. Her practice focuses on individualized cancer treatment planning, including systemic anticancer therapies selected according to tumor characteristics and patient needs.

Education and Academic Qualifications

  • Medical education at Istanbul University, Istanbul Faculty of Medicine, Turkey.

  • Internal Medicine specialty training at Istanbul Training and Research Hospital and Okmeydanı Training and Research Hospital, Istanbul.

  • Medical Oncology specialty training at Istanbul University Institute of Oncology and Okmeydanı Training and Research Hospital.

  • Secondary education at Üsküdar American Academy for Girls, Istanbul, Turkey.

Areas of Interest

  • Medical oncology and cancer treatment in Turkey.

  • Colorectal cancer treatment.

  • Gastrointestinal cancers.

  • Medical treatment of ovarian cancer.

  • Gynecological cancers.

  • Lung cancer treatment.

  • Medical treatment of breast cancer.

  • Urological cancers.

  • Chemotherapy for solid tumors.

  • Cancer immunotherapy when clinically indicated.

  • Targeted cancer therapies based on tumor characteristics.

  • Present (2026): Medical Oncologist at Liv Hospital Ulus, Istanbul, Turkey.

  • Medical Oncology Department, Okmeydanı Training and Research Hospital, Istanbul.

  • Medical Oncology Department, Istanbul University Institute of Oncology.

  • Internal Medicine Department, Okmeydanı Training and Research Hospital, Istanbul.

  • Internal Medicine Department, Istanbul Training and Research Hospital, Ministry of Health, Turkey.

  • Turkish Medical Oncology Association.

  • Istanbul Medical Association.

  • Istanbul Breast Cancer Research Group.

  • Turkish Lung Cancer Association.

  • Üsküdar American Academy Graduates Association.

Asst. Prof. Dr. Meltem Topalgökçeli Selam has contributed to peer-reviewed scientific publications covering ovarian malignancies, chemotherapy for non-small cell lung cancer, targeted anticancer therapies, and immunotherapy for urothelial cancer.

Selected publications:

  • Ovarian carcinosarcomas: Clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum. Gynecologic Oncology, 2008. DOI: 10.1016/j.ygyno.2007.09.003.

  • Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer. Cancer Chemotherapy and Pharmacology, 2007.

  • Psoriasis aggravation due to lapatinib. BMJ Case Reports, 2013.

  • Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences. European Urology Focus, 2021. DOI: 10.1016/j.euf.2020.09.010.

Share :